ABOUT AUSTIN DAVIS BIOLOGICS

​

Austin Davis Biologics (ADB) is a science-based company founded in 2009. It’s a small, fast-moving company that delivers scientific innovations and technology across a range of sectors, from detailed consultancy, to patent support (including expert witness contributions), to project planning and technology evaluation.

 

In the past 15 years Austin Davis Biologics set up its own laboratory with high quality advanced instruments and equipment, enabling the company to develop proprietary technology and IP through an innovative R&D programme focused on equine health. 

 

EquiSal Tapeworm was the first product to be marketed from this R&D programme in 2014. An equivalent blood test for tapeworm in horses was also developed and marketed. The company launched the Small Redworm Blood Test in 2019 following in-depth optimisation and validation studies and completion of a licensing agreement with Moredun Research Institute. Other equine health products are in development, these are primarily focused on diagnostics.

​

Our vision is to bring high quality, rigorous scientific research to bear on equine health, welfare and performance to make effective new products available at affordable prices, improving quality of life for horses and enhancing horse care for owners and professionals.